The MoU was signed in Melbourne by AUScelerate CEO and Managing Director Stuart Dignam and Zhang Hua, Deputy Director of the Shanghai Center of Biomedicine Development.
The agreement, witnessed by the Chairman of the Shanghai Municipal Commission of Science and Technology, Dr Luo Dajin, establishes a three-year collaboration framework.
AUScelerate’s Stuart Dignam says the partnership aims to make a material difference in the way Australian life science innovators engage with Shanghai’s innovation ecosystem.
“China has made biotech a national priority over the last decade and initiatives under its ‘Made in China 2025’ plan have seen centres like Shanghai emerge as powerhouse global clusters,” Mr Dignam said.
“Given the scale of Australia-China collaboration opportunities, we’re delighted to formalise our relationship with the Shanghai Center of Biomedicine Development with today’s MoU signing.
“The MoU will support collaboration activities over the next three years to match Australia’s life sciences capabilities in research, early-stage drug discovery, IP creation and clinical trials with China’s high-level innovation and power in scaling and production.
“We will work together on collaborative programs and events including a talent exchange program, sci-tech exhibitions, roadshows and business matchmaking events while missions between Australia and Shanghai/China will also be supported.
“We’re wasting no time in putting the MoU to work – AUScelerate’s first mission under its new BioGateway China initiative will be to Shanghai and Suzhou from 23-27 November this year and we’ll be delighted to work with our MoU partners to make it a success. Registrations are now open. And next year we’ll be taking Australian companies to China’s leading biotech conference, BIOCHINA in Suzhou from 10-12 March.”
AUScelerate welcomed the delegation from Shanghai Center of Biomedicine Development and the Shanghai Municipal Commission of Science and Technology to its Melbourne HQ.
Chairman of the Shanghai Municipal Commission of Science and Technology, Dr Luo Dajin with AUScelerate CEO and Managing Director Stuart Dignam.
